Celularity Financial Statements From 2010 to 2024

CELU Stock  USD 2.76  0.09  3.16%   
Celularity financial statements provide useful quarterly and yearly information to potential Celularity investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Celularity financial statements helps investors assess Celularity's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Celularity's valuation are summarized below:
Gross Profit
-1.7 M
Profit Margin
(2.64)
Market Capitalization
60.7 M
Enterprise Value Revenue
2.9895
Revenue
42.7 M
There are currently one hundred twenty fundamental signals for Celularity that can be evaluated and compared over time across rivals. All traders should validate Celularity's prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 41.8 M in 2024. Enterprise Value is likely to drop to about 103.7 M in 2024

Celularity Total Revenue

21.45 Million

Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Ebit of 17.2 M or Net Income Applicable To Common Shares of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Celularity Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets136.7 M143.9 M121.3 M
Slightly volatile
Short and Long Term Debt Total79.2 M75.4 M20.8 M
Slightly volatile
Total Current Liabilities70.7 M67.3 M17 M
Slightly volatile
Other Liabilities95.8 M100.9 M279.7 M
Slightly volatile
Accounts PayableM14.1 M6.3 M
Slightly volatile
Cash215.7 K227 K7.1 M
Slightly volatile
Non Current Assets Total117.9 M124.1 M109.1 M
Slightly volatile
Other Assets16.9 M20.6 M9.8 M
Slightly volatile
Cash And Short Term Investments23.4 M16.1 M9.7 M
Slightly volatile
Net Receivables6.6 M10 M4.9 M
Slightly volatile
Common Stock Total Equity201.1 M313.9 M107.3 M
Slightly volatile
Liabilities And Stockholders Equity338.4 M461.2 M155.9 M
Slightly volatile
Inventory5.7 M5.8 M4.3 M
Slightly volatile
Other Current Assets312.6 K329 K1.1 M
Slightly volatile
Other Stockholder EquityB971 M259.3 M
Slightly volatile
Total Liabilities97.8 M102.9 M114 M
Slightly volatile
Total Current Assets30 M19.8 M12.9 M
Slightly volatile
Common Stock12.8 K13.5 K17.2 M
Pretty Stable
Property Plant Equipment69.1 M104.2 M36.5 M
Slightly volatile
Property Plant And Equipment Net91.2 M78.8 M73.6 M
Slightly volatile
Warrants193.9 M188.2 M251 M
Slightly volatile
Good WillM7.3 M110.1 M
Slightly volatile
Common Stock Shares Outstanding11.8 M19.4 M6.4 M
Slightly volatile
Non Current Liabilities Total33.8 M35.6 M114.2 M
Slightly volatile
Capital Surpluse28 M55.6 M16.9 M
Slightly volatile
Non Current Liabilities Other1.8 M1.9 M35 M
Slightly volatile
Intangible Assets10.5 M11 M207 M
Slightly volatile
Current Deferred Revenue2.5 MM4.1 M
Slightly volatile
Capital Lease Obligations23.2 M26.2 M29.7 M
Slightly volatile
Deferred Long Term Liabilities482542590
Slightly volatile
Property Plant And Equipment Gross114.9 M106.1 M100.3 M
Slightly volatile
Capital Stock12.9 K19 K4.7 K
Slightly volatile
Short Term Debt45.4 M43.2 M10.8 M
Slightly volatile
Short and Long Term Debt42.3 M39.2 M38 M
Slightly volatile

Celularity Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization6.6 M10.8 M6.5 M
Pretty Stable
Selling General Administrative48.1 M50.6 M18.1 M
Slightly volatile
Selling And Marketing Expenses139.4 K146.7 K869.7 K
Slightly volatile
Total Revenue21.5 M22.8 M20.6 M
Pretty Stable
Other Operating Expenses118.2 M191.2 M50.3 M
Slightly volatile
Research Development47.4 M30.5 M50.5 M
Slightly volatile
Cost Of Revenue12.4 M16 M8.4 M
Slightly volatile
Total Operating Expenses108.8 M99.2 M41.2 M
Slightly volatile
Interest Income277.4 K320 K357.6 K
Slightly volatile
Reconciled Depreciation9.8 M9.3 M8.5 M
Slightly volatile

Celularity Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation8.6 M9.3 M6.2 M
Slightly volatile
Capital Expenditures3.8 MM6.4 M
Slightly volatile
Total Cash From Financing Activities22.9 M24.1 M90.3 M
Very volatile
End Period Cash Flow9.7 M10.2 M11.4 M
Slightly volatile
Other Cashflows From Investing Activities541 K345 K370.2 K
Slightly volatile
Stock Based Compensation17.4 M15 M8.6 M
Slightly volatile
Begin Period Cash Flow42.7 M28.8 M15.8 M
Slightly volatile
Issuance Of Capital Stock20.8 M21.9 M86 M
Slightly volatile
Dividends Paid31.3 M35.2 M38.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.841.9322129
Slightly volatile
Days Sales Outstanding108194107
Slightly volatile
Average Payables2.1 M2.4 M2.6 M
Slightly volatile
Stock Based Compensation To Revenue0.550.65950.4503
Slightly volatile
Capex To Depreciation0.410.43410.9477
Pretty Stable
EV To Sales4.564.795129
Slightly volatile
Inventory Turnover1.682.78391.9401
Pretty Stable
Days Of Inventory On Hand231131204
Very volatile
Payables Turnover1.081.132423.5768
Pretty Stable
Sales General And Administrative To Revenue1.822.21910.8962
Slightly volatile
Research And Ddevelopement To Revenue2.311.33792.1946
Slightly volatile
Capex To Revenue0.170.17780.357
Slightly volatile
Cash Per Share0.01210.01270.6803
Slightly volatile
Days Payables Outstanding197322268
Pretty Stable
Intangibles To Total Assets0.120.127512.7 K
Slightly volatile
Current Ratio0.280.29410.7414
Slightly volatile
Receivables Turnover3.341.87913.7699
Slightly volatile
Graham Number22.6823.87823.3678
Slightly volatile
Debt To Equity1.010.9580.295
Slightly volatile
Capex Per Share0.220.22731.2009
Pretty Stable
Revenue Per Share1.211.27841.3434
Pretty Stable
Interest Debt Per Share2.492.37220.688
Slightly volatile
Debt To Assets0.140.27270.1088
Slightly volatile
Operating Cycle258325295
Pretty Stable
Days Of Payables Outstanding197322268
Pretty Stable
Total Debt To Capitalization0.260.48930.1877
Slightly volatile
Debt Equity Ratio1.010.9580.295
Slightly volatile
Net Income Per E B T0.781.00010.9158
Pretty Stable
Cash Ratio0.00320.00340.6111
Pretty Stable
Days Of Inventory Outstanding231131204
Very volatile
Days Of Sales Outstanding108194107
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.051.10462.1 K
Slightly volatile
Fixed Asset Turnover0.270.28892.7241
Slightly volatile
Debt Ratio0.140.27270.1088
Slightly volatile
Price Sales Ratio1.841.9322129
Slightly volatile
Asset Turnover0.150.1583426
Slightly volatile

Celularity Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap41.8 M44 M262.6 M
Very volatile
Enterprise Value103.7 M109.2 M291.8 M
Very volatile

Celularity Upcoming Events

2nd of April 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Celularity Financial Statements

Celularity shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred RevenueM2.5 M
Total Revenue22.8 M21.5 M
Cost Of Revenue16 M12.4 M
Stock Based Compensation To Revenue 0.66  0.55 
Sales General And Administrative To Revenue 2.22  1.82 
Research And Ddevelopement To Revenue 1.34  2.31 
Capex To Revenue 0.18  0.17 
Revenue Per Share 1.28  1.21 
Ebit Per Revenue(8.44)(8.02)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.